4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Chemoradiotherapy: new trials by email Literature Review of Chemoradiotherapy trials Research Report on Chemoradiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer PD-1 antibody, Chemoradiation, Albumin-Bound Paclitaxel - Esophagus Cancer, Chemoradiotherapy | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 35 | 2020-10-01 | 2025-05-30 |
| A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer Radiotherapy, Nimotuzumab, S-1 - Esophageal Cancer, Chemoradiotherapy | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 55 | 2019-11-14 | 2024-05-16 |
| Non-OpeRative MANagement of Rectal Cancer Patients Capecitabine - Rectal Cancer, Chemoradiotherapy | Phase 2 | Completed | Kangbuk Samsung Hospital | 18 | 2018-02-01 | 2025-02-12 |
| A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma SIB-IMRT, S-1, Surgery - Stomach Neoplasms, Neoadjuvant Therapy | Phase 2 | Completed | Chinese Academy of Medical Sciences | 71 | 2014-01-01 | 2019-10-16 |
Esophageal Neoplasms (2) · Rectal Neoplasms (1) · Stomach Neoplasms (1)
Digestive System Diseases (4) · Digestive System Neoplasms (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Neoplasms (4) · Neoplasms by Site (4) · Esophageal Diseases (2) · Head and Neck Neoplasms (2) · Colorectal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Rectal Diseases (1) · Stomach Diseases (1)
S 1 (combination) (2) · Albumin-Bound Paclitaxel (1) · Capecitabine (1) · Chemoradiotherapy (1) · Cisplatin (1) · Injections (1) · Oxaliplatin (1) · Radiotherapy (1) · Surgical Procedures, Operative (1) · nimotuzumab (1) · spartalizumab (1) · titanium silicide (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (2) · Chinese Academy of Medical Sciences (1) · Kangbuk Samsung Hospital (1)
China (3) · South Korea (1)
Dong-Hoe Koo (1)